Please login to the form below

Not currently logged in
Email:
Password:

Protein Sciences

This page shows the latest Protein Sciences news and features for those working in and with pharma, biotech and healthcare.

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences

Manon M.J. Cox, Protein Sciences’ president and CEO, added: "Protein Sciences was actively looking for an opportunity to grow its business, particularly in the US. ... Its deal with Protein Sciences follows unsuccessful bids in the last year for

Latest news

  • Budget deal brings FDA back to life Budget deal brings FDA back to life

    Advisory committee meetings continued and there were a few new product approvals and alerts, although there are reports of delays for some products including a flu vaccine made by Protein Sciences.

  • FDA approves first egg-free flu vaccine Flublok FDA approves first egg-free flu vaccine Flublok

    production. Instead, the vaccine, which was developed by Protein Sciences in partnership with the US Department of Health and Human Services, is produced using  an insect virus (baculovirus). ... Protein Sciences is also developing Panblok in

  • Early identification key for healthcare

    The meeting also heard about the growing antibodies market. Lotta Ljungqvist, head of R&D BioTechnologies, Life Sciences at GE Healthcare Sweden, said: "There will be more protein-based drugs available ... The region has already attracted AstraZeneca, GE

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2015 Deal Watch October 2015

    Regaining of rights. 564. Alpine Immune Sciences/ Kite Pharma. 2 transmembrane immunomodulatory protein (TIP) programmes (discovery). ... Collaboration - R&D. 126. †† Genexine/ Tasgen Bio-Tech. 3 clinical and 2 preclinical therapeutic protein/

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    172. Nerviano Medical Sciences / Servier . Collaboration, licence, option. Protein kinase TTK/MPS1 inhibitors (preclinical).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • F-star appoints vice president of protein sciences F-star appoints vice president of protein sciences

    Mike Davies joins from CPI Biologics. Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site. ... His strong experience in the development and

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics